Background illustration for clinical trials search

Paid Clinical Trials Pittsburgh

Discover 1,166 paid clinical trials in Pittsburgh, Pennsylvania. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Phase II Study of Glucocerebrosidase in Patients With Gaucher Disease

for
Gaucher's Disease
Location: Pittsburgh PA
Sponsor: National Center for Research Resources (NCRR)

Sex: All

Age: 18 - 65

Code: NCT00004293

Phase 2, Recruiting

A Study of MF101 in Postmenopausal Women

for
Hot Flushes, Vasomotor Symptoms
Location: Pittsburgh PA, Cleveland OH, Columbus OH,
Sponsor: Bionovo

Sex: Female

Age: 40 - 65

Code: NCT00906308

Phase 3, Recruiting

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

for
Crohn's Disease
Location: Pittsburgh PA, Canton OH, Cleveland OH, Westlake OH,
Sponsor: Sanofi

Sex: All

Age: 16 - 70+

Code: NCT07184931

Phase 3, Recruiting

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

for
Ulcerative Colitis
Location: Pittsburgh PA, Canton OH, Westlake OH, Columbus OH,
Sponsor: Sanofi

Sex: All

Age: 16 - 70+

Code: NCT07184996

Phase 3, Recruiting

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

for
Crohn's Disease
Location: Pittsburgh PA, Westlake OH, Columbus OH, London,
Sponsor: Sanofi

Sex: All

Age: 16 - 70+

Code: NCT07184944

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE

for
Aortic Stenosis
Location: Pittsburgh PA, Cleveland OH, Mechanicsburg PA,
Sponsor: Medtronic Cardiovascular

Sex: All

Age: 18 - 70+

Code: NCT06777368

Recruiting

A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)

for
Healthy Volunteers, Pulmonary Arterial Hypertension
Location: Pittsburgh PA, Richmond VA, Louisville KY, Knoxville TN,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT06649110

Phase 1, Phase 2, Recruiting

Clinical Equivalence of Azelastine Hydrochloride and Fluticasone Propionate, 137/50 mcg Nasal Spray to Dymista™

for
Seasonal Allergic Rhinitis
Location: Pittsburgh PA
Sponsor: Teva Pharmaceuticals USA

Sex: All

Age: 12+

Code: NCT02249663

Phase 3, Recruiting
Featured

A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression Treated With Intravenously (IV) Infused Mirvetuximab Soravtansine

for
Advanced High-Grade Epithelial Ovarian Cancer,
Location: Pittsburgh PA, Detroit MI, Edgewood KY, Lexington KY,
Sponsor: AbbVie

Sex: Female

Age: 18+

Code: NCT06682988

Phase 2, Recruiting

Musculoskeletal Impairment in Headaches Attributed to Rhinosinusitis

for
Headache
Location: Youngstown OH, Havertown PA, Lafayette NJ, Totowa NJ,
Sponsor: Des Moines University

Sex: All

Age: 18 - 65

Code: NCT04222244

Recruiting

Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

for
Pulmonary Disease, Chronic Obstructive
Location: Morgantown WV, DuBois PA, Rockville MD, Allen Park MI,
Sponsor: GlaxoSmithKline

Sex: All

Age: 40 - 70+

Code: NCT06961214

Phase 3, Recruiting

Galvanize Prospective/Retrospective Pulsed Electric Field Device Registry

for
Soft Tissue Lesion
Location: Morgantown WV, Wynnewood PA, Durham NC, New York NY,
Sponsor: Galvanize Therapeutics, Inc.

Sex: All

Age: 18 - 70+

Code: NCT05851430

Recruiting

A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

for
Ovarian Cancer
Location: Morgantown WV, Columbus OH, Hilliard OH, Hershey PA,
Sponsor: Incyte Corporation

Sex: Female

Age: 18 - 70+

Code: NCT07023627

Phase 2, Recruiting

Study to Assess the Efficacy and Safety of Rina-S With or Without Bevacizumab Compared to Investigator's Choice of Platinum-based Chemotherapy With or Without Bevacizumab as Second-line Treatment in Participants With Recurrent Platinum-sensitive Ovarian Cancer

for
Platinum-Sensitive Ovarian Cancer, Ovarian Cancer
Location: Morgantown WV, Bensalem PA, Danbury CT, Waukesha WI,
Sponsor: Genmab

Sex: Female

Age: 18+

Code: NCT07564141

Phase 3, Recruiting

Clarifying the Optimal Application of SLT Therapy Trial

for
Glaucoma and Ocular Hypertension
Location: Morgantown WV, Cleveland OH, Baltimore MD, Detroit MI,
Sponsor: University of Pittsburgh

Sex: All

Age: 18+

Code: NCT04967989

Phase 3, Recruiting

Middle Meningeal Artery Embolization (MMAE) Outcomes for Chronic Subdural Hematoma (cSDH)

for
Chronic Subdural Hematoma
Location: Morgantown WV, Toronto, Philadelphia PA, The Bronx NY,
Sponsor: Montefiore Medical Center

Sex: All

Age: 18+

Code: NCT06181994

Recruiting

Longitudinal Performance of Epi proColon

for
Colorectal Cancer, Colorectal Neoplasms
Location: Morgantown WV, Danville PA, Royal Oak MI,
Sponsor: Epigenomics, Inc

Sex: All

Age: 50 - 70+

Code: NCT03218423

Recruiting

Study of Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab in HER2-Negative Breast Cancer Patients With Abnormal HER2 Signaling

for
HER2-negative Breast Cancer
Location: Morgantown WV, Canton OH, Marietta OH, Zanesville OH,
Sponsor: NSABP Foundation Inc

Sex: Female

Age: 18+

Code: NCT03412643

Phase 2, Recruiting

Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body

for
Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion,
Location: Morgantown WV, Baltimore MD, Philadelphia PA,
Sponsor: Bayer

Sex: All

Age: 0+

Code: NCT04142437

Recruiting

Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial

for
Muscle Invasive Bladder Urothelial Carcinoma,
Location: Morgantown WV, Cleveland OH, Parkersburg WV,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT07061964

Phase 2, Recruiting